This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Avastin
  • /
  • Reolysin in Combination With FOLFOX6 and Bevacizum...
Clinical trial

Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer

Read time: 1 mins
Last updated:11th Jun 2012
Source: Clinical Trials
Identifier: NCT01622543

The purpose of this study is to find out if giving reolysin in combination with FOLFOX6/ bevacizumab can offer better results than standard therapy with FOLFOX6/ bevacizumab.


Study Type:
Interventional (Clinical Trial)
Actual Enrollment: 109 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Phase II Study of Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Patients With Metastatic Colorectal Cancer.
Actual Study Start Date: June 11, 2012
Actual Primary Completion Date: January 18, 2017
Actual Study Completion Date: September 12, 2018

Arms:
- Active Comparator: Folfox plus Bevacizumab and Reolysin
- Active Comparator: Folfox plus Bevacizumab

Category Value
Date last updated at source 2012-06-12
Study type(s) Interventional
Expected enrolment 109
Study start date 2012-06-11
Estimated primary completion date 2017-12-01

View full details